- Home
- IRMD vs CRMD Comparison
IRMD vs CRMD Comparison
Compare IRMD & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- CRMD
- Stock Information
- Founded
- IRMD 1992
- CRMD 2006
- Country
- IRMD United States
- CRMD United States
- Employees
- IRMD N/A
- CRMD N/A
- Industry
- IRMD Medical/Dental Instruments
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- IRMD Health Care
- CRMD Health Care
- Exchange
- IRMD Nasdaq
- CRMD Nasdaq
- Market Cap
- IRMD 924.2M
- CRMD 925.6M
- IPO Year
- IRMD 2014
- CRMD 2010
- Fundamental
- Price
- IRMD $70.76
- CRMD $11.12
- Analyst Decision
- IRMD Strong Buy
- CRMD Strong Buy
- Analyst Count
- IRMD 1
- CRMD 8
- Target Price
- IRMD $72.00
- CRMD $17.57
- AVG Volume (30 Days)
- IRMD 38.5K
- CRMD 4.6M
- Earning Date
- IRMD 10-30-2025
- CRMD 10-29-2025
- Dividend Yield
- IRMD 0.95%
- CRMD N/A
- EPS Growth
- IRMD 10.28
- CRMD N/A
- EPS
- IRMD 1.61
- CRMD 0.79
- Revenue
- IRMD $77,635,163.00
- CRMD $121,484,498.00
- Revenue This Year
- IRMD $13.76
- CRMD $404.81
- Revenue Next Year
- IRMD $10.38
- CRMD $56.11
- P/E Ratio
- IRMD $44.39
- CRMD $14.00
- Revenue Growth
- IRMD 11.73
- CRMD 14970.29
- 52 Week Low
- IRMD $46.86
- CRMD $5.60
- 52 Week High
- IRMD $74.43
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- IRMD 51.41
- CRMD 34.64
- Support Level
- IRMD $71.00
- CRMD $12.73
- Resistance Level
- IRMD $74.43
- CRMD $13.83
- Average True Range (ATR)
- IRMD 1.59
- CRMD 0.81
- MACD
- IRMD -0.52
- CRMD -0.30
- Stochastic Oscillator
- IRMD 15.52
- CRMD 0.90
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.